The stock trades below ... they emit detectable gamma radiation into tumors. This way, CATX's IP can potentially help with tumor images, which is essential for oncology diagnostics.

On Monday, H.C. Wainwright adjusted its outlook on Pyxis Oncology Inc. (NASDAQ:PYXS), reducing the price target to $5.00 from the previous $7.00, but retained a Buy rating on the stock. Currently ...

Selvaraju projected fourth-quarter revenue of $2.9 million and EPS of $(0.10). Price Action: ACRS stock is up 8% at $2.94 at last check Monday.

The company said the contract is to support the continued development and demonstration of Strategic Radiation Hardened high-reliability Field Programmable Gate Array technology. The contract ...

On Monday, H.C. Wainwright adjusted its outlook on Pyxis Oncology Inc. (NASDAQ:PYXS), reducing the price target to $5.00 from the previous $7.00, but retained a Buy rating on the stock.

Free: Portfolio tracking, stock and ETF screener, stock research tools, stock comparison Premium: From $7.49 per month. Link unlimited accounts, portfolio simulator, top 50 stock list, Ziggma ...

SAN DIEGO - Kura Oncology, Inc. (NASDAQ:KURA), a pharmaceutical company specializing in the development of cancer therapies with a market capitalization of approximately $704 million, announced an ...

The best free cloud storage allows you to securely save a copy of your most important files in the cloud for safekeeping. Whether they be documents, images or even videos, these free services by ...

It includes medical oncology (the use of chemotherapy, hormone therapy, and other drugs to treat cancer), radiation oncology (the use of radiation therapy to treat cancer), and surgical oncology ...

Investing.com -- Shares of Alx Oncology (NASDAQ:ALXO) fell in pre-market trading Thursday after Jefferies downgraded the stock to "hold" rating from a "buy," citing concerns ... The study's objective ...